At the time of writing, Wave Life Sciences Ltd. [WVE] stock is trading at $6.51, down -0.31%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The WVE shares have gain 5.43% over the last week, with a monthly amount glided 30.46%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Wave Life Sciences Ltd. [NASDAQ: WVE] stock has seen the most recent analyst activity on May 15, 2024, when Wells Fargo initiated its Overweight rating and assigned the stock a price target of $11. Previously, Leerink Partners upgraded its rating to Outperform on December 19, 2023, and elevated its price target to $12. On July 05, 2023, Raymond James initiated with a Outperform rating and assigned a price target of $7 on the stock. Jefferies downgraded its rating to a Hold and decreased its price target to $5 on May 24, 2023. RBC Capital Mkts started tracking with a Sector Perform rating for this stock on October 23, 2020, and assigned it a price target of $13. In a note dated December 31, 2019, SVB Leerink downgraded an Mkt Perform rating on this stock and revised its target price from $33 to $10.
For the past year, the stock price of Wave Life Sciences Ltd. fluctuated between $3.50 and $7.67. Currently, Wall Street analysts expect the stock to reach $14 within the next 12 months. Wave Life Sciences Ltd. [NASDAQ: WVE] shares were valued at $6.51 at the most recent close of the market. An investor can expect a potential return of 115.05% based on the average WVE price forecast.
Analyzing the WVE fundamentals
According to Wave Life Sciences Ltd. [NASDAQ:WVE], the company’s sales were 112.91M for trailing twelve months, which represents an -3.02% plunge. Gross Profit Margin for this corporation currently stands at 0.92% with Operating Profit Margin at -0.64%, Pretax Profit Margin comes in at -0.55%, and Net Profit Margin reading is -0.55%. To continue investigating profitability, this company’s Return on Assets is posted at -0.26, Equity is 21.56 and Total Capital is -1.04. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.92.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 6.37 points at the first support level, and at 6.22 for the second support level. However, for the 1st resistance point, the stock is sitting at 6.61, and for the 2nd resistance point, it is at 6.71.
Ratios To Look Out For
It is important to note that Wave Life Sciences Ltd. [NASDAQ:WVE] has a current ratio of 1.19. Also, the Quick Ratio is 1.19, while the Cash Ratio stands at 1.09. Considering the valuation of this stock, the price to sales ratio is 7.06, the price to book ratio is 31.36.
Transactions by insiders
Recent insider trading involved Moran Kyle, Chief Financial Officer, that happened on Apr 03 ’24 when 15630.0 shares were sold. Director, RA CAPITAL MANAGEMENT, L.P. completed a deal on Dec 11 ’23 to buy 1.0 million shares. Meanwhile, 10% Owner GSK plc bought 3.3 million shares on Dec 07 ’23.
